Praxis Precision Medicines (PRAX) Misses Q4 EPS by 41c

Praxis Precision Medicines (NASDAQ: PRAX) reported Q4 EPS of ($3.50), $0.41 worse than the analyst estimate of ($3.09).

For earnings history and earnings-related data on Praxis Precision Medicines (PRAX) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• Trifecta Gold closes $1.66M private placement for Yukon exploration
• RBC Capital Upgrades GEA Group AG (G1A:GR) (GEAGY) to Outperform